Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. This story has been updated. Moderna has ...

Pharmaceutical companies Moderna and Merck announced today the highly promising results of their anti-cancer mRNA vaccine Phase 3 clinical trial targeting later-stage melanoma skin cancers.

Coller is Bloomberg distinguished professor of RNA biology and therapeutics at Johns Hopkins University and a co-founder of the Alliance for mRNA Medicines. On Wednesday, the Food and Drug ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. discusses the findings of the Centers for ...

・MRNA’s significant rally began in mid-August, when the company announced late-stage trial results for its cancer vaccine. ・“Moderna has never been a COVID-19 vaccine company,” the CEO said at a ...

SA Spotlight uses AI to summarize content published on Seeking Alpha. All summaries are reviewed by human editors prior to publication. Investors Should Know: Personalized mRNA cancer vaccines are ...

An estimated 2.1 million new cancer cases will be diagnosed in the United States this year and an estimated 626 thousand will die, according to the American Cancer Society. However, there may be hope ...